DxPx Europe ’25 is the premier international partnering event for stakeholders in Diagnostics, Digital Health, Precision Medicine, and Life Science Tools. Taking place in Munich, Germany, on September 26th and 27th, the event is a hub for M&A, licensing, and financing discussions, attracting leading investors, industry experts, and innovators. The event features an impressive lineup, including 20 exhibitors showcasing cutting-edge innovations at Startup City, 4 expert-led panels offering invaluable insights, and the highly anticipated pitch award. DxPx Europe ’25 promises to be an inspiring platform for fostering collaborations, driving innovation, and shaping the future of healthcare technology.
Hawk Biosystems is proud to announce that our CEO, Fernando Aguirre de Miguel, will be attending DxPx Europe ’25. This event offers an unparalleled opportunity to engage with industry leaders, investors, and innovators who share a passion for advancing life sciences through diagnostics and precision medicine.
Fernando is looking forward to connecting with potential partners, exchanging ideas, and exploring collaborations that align with Hawk Biosystems’ mission to transform healthcare through cutting-edge spatial biology solutions. If you’re attending DxPx Europe ’25, don’t miss the chance to meet with him and discuss how we can work together to push the boundaries of innovation in life sciences.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.